Full Paper
tography (Al2O3) with a mixture of CHCl3/MeOH (35:1) as the eluent
to give a red suspension, which was stirred and then heated under
reflux for 24 h. The mixture was extracted with a dilute solution of
sodium thiosulfate to remove any excess bromine. The crude prod-
uct was washed with water and dried in vacuo to give a faint yellow
to afford 1b as a red powder (325 mg, 34 %) after the removal of
1
uncomplexed S3b; m.p. >300 °C. H NMR (500 MHz, CD3OD/CDCl3
1:1, 300 K): δ = 9.34 (s, 4 H, tpyHcomplex 3′,5′), 9.11 (d, J3,3′′-4,4′′
=
6.0 Hz, 4 H, tpyHcomplex 3,3′′), 8.73 (s, 4 H, tpyHfree 3′,5′), 8.67–8.64 (m, solid, which was further rinsed with acetone and EtOH and dried
J3,3′′-4,4′′ = 4.0 Hz, J6,6′′-5′,5′′ = 7.5 Hz, 8 H, tpyHfree 3,3′′, tpyHfree 6,6′′),
to afford 1 as a white solid (7.42 g, 46 %); m.p. 252–268 °C (ref.[9]
247–264 °C). 1H NMR (500 MHz, CDCl3, 300 K): δ = 7.23 (s, 4 H, PhH)
ppm. 13C NMR (300 MHz, CDCl3, 300 K): δ = 138.91, 132.44, 125.27
ppm. MALDI-TOF MS: m/z = 528.46 [C12H4Br4S2+H]+ (calcd. 528.65).
8.32 (d, Ja - b = 4.5 Hz, 4 H, PhHc o m p l e x a ), 7.91–7.88 [m,
J3,3′′-4,4′′(complex) = 6.0 Hz, J4,4′′-5,5′′(complex) = 2.5 Hz, J3,3′′-4,4′′(free)
=
4.0 Hz, J4,4′′-5,5′′(free) = 3.5 Hz, 8 H, tpyHfree 4,4′′, tpyHcomplex 4,4′′], 7.80
(d, Ja-b = 2.5 Hz, PhHfree a), 7.55–7.46 [m, Jf-e(complex) = 0.6 Hz,
Jf-g(complex) = 1.0 Hz, Jf-e(free) = 0.4 Hz, Jf-g(free) = 0.8 Hz, 8 H,
PhHcomplex f, PhHfree f], 7.45 (d, Jb-a = 4.5 Hz, 4 H, PhHcomplex b), 7.42
2,3,7,8-Tetrakis[4-(2,2′:6′,2′′-terpyridin-4′-yl)phenyl]thianthrene
(2): Compound 1 (1.06 g, 2.00 mmol), 2[10] (4.24 g, 12.00 mmol),
Na2CO3 (5.30 g, 50 mmol), and a solvent mixture of toluene
(250 mL), H2O (150 mL), and EtOH (100 mL) were added to a 1 L
flask. The system was subjected to freeze–pump–thaw cycles (3 ×)
and back-filled with argon, and PdCl2(PPh3)2 (246 mg, 350 μmol)
was added. The resultant mixture was heated under reflux under
argon. The reaction mixture was cooled to 25 °C, and the aqueous
layer was extracted with CHCl3 (3 × 200 mL). The combined organic
phase was dried (MgSO4) and then concentrated in vacuo to give
a whitish yellow residue, which was purified by flash column chro-
matography (Al2O3) with a mixture of hexane, EtOAc, and CHCl3
(3:1:1 v/v/v) as the eluent to give 3 as an off-white solid (2.14 g,
[m, J5,5′′-4,4′′ = 2.5 Hz, J5,5′′-6,6′′ = 0.6 Hz, Jf-g(complex) = 1.0 Hz, Jf-g(free)
0.8 Hz, 8 H, tpyHcomplex 5,5′′, PhHcomplex g, PhHfree g], 7.36–7.34 [m,
Jb-a = 2.5 Hz, Jf-e(complex) = 0.6 Hz, Jf-e(free) = 0.4 Hz, 12 H, PhHfree b
PhHcomplex e, PhHfree e], 7.30 (d, J5,5′′-6,6′′ = 0.6 Hz, 4 H, tpyHcomplex 6,6′′),
7.22 (s, 2 H, PhHcomplex c), 7.18 (dd, J5,5′′-6,6′′ = 7.5 Hz, J5,5′′-4,4′′
=
,
=
3.5 Hz, 4 H, tpyHfree 5,5′′), 7.13 (s, 2 H, PhHfree c), 5.31 (s, 2 H,
PhHcomplex d), 5.29 (s, 2 H, PhHfree d) ppm. 13C NMR (125 MHz, CDCl3/
MeOD 2:1 v/v, 300 K): δ = 158.41, 155.67, 152.14, 150.67, 149.30,
149.05, 148.66, 144.41, 142.94, 138.94, 137.39, 137.31, 136.32,
134.48, 133.83, 133.22, 133.04, 131.69, 131.20, 128.95, 128.43,
127.99, 127.97, 127.81, 127.33, 125.50, 124.97, 122.72, 121.80,
120.58, 119.43, 117.99, 117.88, 72.26, 72.07 ppm. ESI-MS: m/z =
2055.57 [M – PF6]+ (calcd. 2055.57).
1
74 %); m.p. 225 °C. H NMR (500 MHz, CDCl3, 300 K): δ = 8.74 (s, 2
H, tpyH3′,5′), 8.69 (d, J3,3′′-4,4′′ = 4 Hz, 2 H, tpyH3,3′′), 8.65 (d, J6,6′′-5,5′′
=
6 Hz, 2 H, tpyH6,6′′), 7.87 (dd, J4,4′′-3,3′′ = J5,5′′-4,4′′ = 4 Hz, 2 H, tpyH4,4′′),
7.84 (d, Ja-b = 3 Hz, 2 H, PhHa), 7.71 (s, 1 H, PhHc), 7.34 (d, Jb-a
3,4-Bis(4-terpyridyl-p-phenyl)-o-dimethoxybenzene (S3c):[6b]
=
3 Hz, 2 H, PhHb), 7.32 (dd, J5,5′′-6,6′′ = 6 Hz, J5,5′′-4,4′′ = 4 Hz, 2 H,
tpyH5,5′′) ppm. 13C NMR (300 MHz, CDCl3, 300 K): δ = 156.27, 155.93,
149.78, 149.15, 139.98, 137.16, 137.10, 135.02, 130.90, 130.40,
127.38, 123.93, 121.51, 119.03 ppm. MALDI-TOF MS: m/z = 1446.74
[C96H60N12S2+H]+ (calcd. 1446.45).
1
M.p. 267.3–268.5 °C. H NMR (500 MHz, CDCl3, 300 K): δ = 8.75 (s,
2 H, tpyH3′,5′), 8.69 (d, J6,6′′-5,5′′ = 7 Hz, 2 H, tpyH6,6′′), 8.65 (d,
J
3,3′′-4,4′′ = 8 Hz, 2 H, tpyH3,3′′), 7.85 (m, 4 H, tpyH4,4′′, PhHa), 7.33 (m,
4 H, tpyH5,5′′, PhHb), 7.03 (s, 1 H, PhHc), 4.01 (s, 1 H, PhHd) ppm. 13C
NMR (300 MHz, CDCl3, 300 K): δ = 56.2, 113.6, 118.7, 123.7, 127.0,
130.5, 136.3, 142.2, 148.5, 149.1, 155.8, 156.2 ppm. ESI-MS: m/z =
753.3 [M + H]+ (calcd. 753.9).
[Ru2Zn4(2)(1a)4(PF6)12] (3a): To a solution of ligand 2 (2.17 mg,
15.0 μmol) and dimer 1a (7.56 mg, 30.0 μmol) in a solvent mixture
of CHCl3/MeOH (12 mL, 1:1), a solution of Zn(NO3)2·6H2O (1.79 mg,
60.0 μmol) in MeOH (6 mL) was added. The mixture was stirred for
1 h, and excess NH4PF6 was added to afford a dark red precipitate,
which was washed thoroughly with water and MeOH to give the
[Ru(S3c)2Cl2]: To a 1 L round-bottomed flask were added S3c
(750 mg, 1.0 mmol), RuCl2(DMSO)4 (162 mg, 333 μmol), and a sol-
vent mixture of CHCl3/MeOH (1:1, 700 mL), and then the mixture
was heated under reflux for 48 h. The reaction was concentrated in
vacuo to give a red powder, which was purified by column chroma-
tography (Al2O3) with CHCl3/MeOH (35:1) as the eluent to afford 1c
as a red powder (168 mg, 29 %) upon the removal of uncomplexed
S3c; m.p. >300 °C. 1H NMR (500 MHz, CD3OD/CDCl3 1:1, 300 K): δ =
9.36 (s, 4 H, tpyH complex 3′,5′), 9.14 (d, J3,3′′-4,4′′ = 6.5 Hz, 4 H,
tpyHcomplex 3,3′′), 8.71 (s, 4 H, tpyHfree 3′,5′), 8.62 (m, J3,3′′-4,4′′ = 4 Hz,
J6,6′′-5,5′′ = 1 Hz, 8 H, tpyHfree 3,3′′, tpyHfree 6,6′′), 8.32 (d, Ja-b = 5 Hz, 4
H, PhHcomplex a),7.84 [dd, J3,3′′-4,4′′(free) = 4 Hz, J4,4′′-5,5′′(free) = 3.5 Hz,
–
desired 3a with PF6 counterions as a dark red powder (11.75 mg,
1
95 %); m.p. >300 °C. H NMR (500 MHz, CD3CN, 300 K): δ = 8.99 (s,
8 H, tpyAH3′,5′), 8.97 (s, 8 H, tpyBH3′,5′), 8.97 (s, 8 H, tpyCH3′,5′), 8.70
[d, J3,3′′-4,4′′(B) = 6.5 Hz, 16 H, tpyBH3,3′′, J3,3′′-4,4′′(C) = 4.0 Hz, tpyCH3,3′′],
8.63 [d, J3,3′′-4,4′′(A) = 6.5 Hz, 8 H, tpyAH3,3′′], 8.17 [d, Ja-b(A) = 3.0 Hz,
8 H, PhAHa], 8.12 [d, Ja-b(B) = 2.5 Hz, Ja-b(C) = 2.5 Hz, 16 H, PhBHa,
PhCHa], 8.07 [d, 16 H, J3,3′′-4,4′′(B) = 6.5 Hz, J4,4′′-5,5′′(B) = 3.5 Hz,
J3,3′′-4,4′′(C) = 4.0 Hz, J4,4′′-5,5′′(C) = 2.5 Hz, tpyBH4,4′′, tpyCH4,4′′], 7.95 (s,
4 H, PhCHc), 7.84 [m, J3,3′′-4,4′′(A) = 6.5 Hz, J4,4′′-5,5′′(A) = 4.5 Hz,
J3,3′′-4,4′′(complex) = 5 Hz, J4,4′′-5,5′′(complex) = 3.5 Hz, 8 H, tpyHfree 4,4′′
,
J5,5′′-6,6′′(B) = 2.5 Hz, J5,5-6,6′′(C) = 1.0 Hz, 24 H, tpyAH4,4, tpyBH6,6′′
,
tpyHcomplex 4,4′′], 7.78 (d, Ja-b = 2.5 Hz, 4 H, PhHfree a), 7.48 (d,
tpyCH6,6′′], 7.61 [m, Ja-b(A) = 3.0 Hz, Ja-b(B) = 2.5 Hz, Ja-b(C) = 2.5 Hz,
24 H, PhAHb, PhBHb, PhCHb], 7.41 [d, J5,5-6,6′′(A) = 3.5 Hz, 8 H,
tpyAH6,6′′], 7.35 [dd, 16 H, J4,4′′-5,5′′(B) = 3.5 Hz, J5,5′′-6,6′′(B) = 2.5 Hz,
J4,4′′-5,5′′(C) = 2.5 Hz, J5,5-6,6′′(C) = 1.0 Hz, tpyBH5,5′′, tpyCH5,5′′], 7.25 (s,
4 H, PhAHc), 7.23 (s, 4 H, PhBHc), 7.14 [dd, J4,4′′-5,5′′(A) = 4.5 Hz,
J5,5-6,6′′(A) = 3.5 Hz, 8 H, tpyAH5,5′′], 4.21 (t, 16 H, JC1-C2 = 12 Hz, 8 ×
CH2), 1.88 (tt, 16 H, JC2-C1 = 12 Hz, JC2-C3 = 2 Hz, 8 × CH2), 1.58 (tt,
J6,6′′-5′,5′′ = 1 Hz, 4 H, tpyHcomplex 6,6′′), 7.33–7.29 [m, Jb-a(complex)
5 Hz, Jb-a(free) = 2.5 Hz, J5,5′′-4,4′′(complex) = 3.5 Hz, J5,5′′-6,6′′(complex)
=
=
1 Hz, 12 H, Ph-Hcomplex b, PhHfree b, tpyHcomplex 5,5′′], 7.12 [dd,
J5,5′′-4,4′′(free) = 3.5 Hz, J5,5′′-6,6′′(free) = 1 Hz, 4 H, tpyHfree 5,5′′], 7.07 (s,
1 H, PhHcomplex c), 6.98 (s, 1 H, PhHfree c), 3.98 (s, 1 H, PhHcomplex d),
3.95 (s, 1 H, PhHfree d) ppm. 13C NMR (300 MHz, CD3OD/CDCl3 1:1,
300 K): δ = 173.4, 157.8, 155.9, 155.0, 151.7, 149.5, 149.0, 148.7,
148.6, 148.5, 143.9, 142.3, 138.3, 137.1, 136.1, 166.9, 132.4, 131.9,
131.3, 130.6, 127.9, 127.5, 126.9, 125.1, 124.0, 121.4, 118.4, 116.6,
113.7, 56.2, 56.1 ppm. MALDI-MS: m/z = 1668.01 [M – NO3]+ (calcd.
1668.01).
J
C3-C2 = 2 Hz, JC3-C4 = 0.6 Hz, 16 H, 8 × CH2), 1.45 (tt, JC4-C3 = 0.6 Hz,
JC4-C5 = 1 Hz, 16 H, 8 × CH2), 1.42–1.29 (m, 176 H, 88 × CH2), 0.88
(t, 24 H, J = 2 Hz, 8 × CH3) ppm. 13C NMR (500 MHz, CD3CN, 300 K):
δ = 172.90, 171.07, 166.12, 159.17, 156.26, 150.84, 150.77, 148.95,
148.87, 148.82, 142.18, 142.16, 139.00, 138.13, 132.32, 132.12,
128.95, 128.65, 128.53, 128.50, 128.47, 124.25, 124.20, 122.43,
122.39, 32.64, 30.42, 30.37, 30.12, 30.07, 26.91, 23.38 ppm. ESI-MS:
2,3,7,8-Tetrabromothianthrene (S5): To thianthrene (6.48 g,
30 mmol) in a flask, bromine (38.4 g, 24 mmol) was added, and an
immediate reaction (take care) occurred with the evolution of HBr m/z = 1245.3 [M – 6PF6]6+ (calcd. 1244.1), 1046.9 [M – 7PF6]7+ (calcd.
gas. Then, glacial acetic acid (20 mL) was added to the black solid
1045.7), 897.7 [M – 8PF6]8+ (calcd. 896.9), 781.9 [M – 9PF6]9+ (calcd.
Eur. J. Inorg. Chem. 2016, 1671–1677
1675
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim